Gastric Band Competition in the Bariatric Surgery Market
Allergan, J&J face off in obesity market
October 12, 2007: 03:32 PM EST
Oct. 12, 2007 (Thomson Financial delivered by Newstex) --
NEW YORK (AP) - The recent approval of Johnson & Johnson's (NYSE:JNJ) Realize gastric band has stepped up competition in the surgical weight-loss market, which until now has been dominated by Allergan's (NYSE:AGN) Lap-Band.
The Lap-Band and Realize are adjustable gastric bands, which are surgically implanted around the stomach to help severely obese adult patients lose weight by forcibly limiting food intake. This procedure presents an alternative to more invasive gastric bypass surgery, commonly known as stomach stapling.
Analysts predict the Realize will cost about the same as the Lap-Band procedure, roughly $12,000 to $20,000. In what could be a fierce battle for market share, some analysts see the companies eventually splitting the market.
Irvine, Calif.-based Allergan, which also makes Botox, acquired the Lap-Band with its 2006 purchase of Inamed and has so far faced no competition in the U.S. market. But on Sept. 28, J&J's Ethicon Endo-Surgery Inc. unit said the Food and Drug Administration cleared its Realize band, ending Allergan's honeymoon a few months earlier than expected.
J&J plans to launch Realize in December; analysts hadn't expected approval until the end of the year or early 2008. More >>
Bariatric Surgery Attorney
October 12, 2007: 03:32 PM EST
Oct. 12, 2007 (Thomson Financial delivered by Newstex) --
NEW YORK (AP) - The recent approval of Johnson & Johnson's (NYSE:JNJ) Realize gastric band has stepped up competition in the surgical weight-loss market, which until now has been dominated by Allergan's (NYSE:AGN) Lap-Band.
The Lap-Band and Realize are adjustable gastric bands, which are surgically implanted around the stomach to help severely obese adult patients lose weight by forcibly limiting food intake. This procedure presents an alternative to more invasive gastric bypass surgery, commonly known as stomach stapling.
Analysts predict the Realize will cost about the same as the Lap-Band procedure, roughly $12,000 to $20,000. In what could be a fierce battle for market share, some analysts see the companies eventually splitting the market.
Irvine, Calif.-based Allergan, which also makes Botox, acquired the Lap-Band with its 2006 purchase of Inamed and has so far faced no competition in the U.S. market. But on Sept. 28, J&J's Ethicon Endo-Surgery Inc. unit said the Food and Drug Administration cleared its Realize band, ending Allergan's honeymoon a few months earlier than expected.
J&J plans to launch Realize in December; analysts hadn't expected approval until the end of the year or early 2008. More >>
Bariatric Surgery Attorney
Labels: bariatric surgery, gastric band, weight loss surgery business
0 Comments:
Post a Comment
<< Home